Impact Therapeutics

China - ShanghaiBiotechnology1 H-1B visas (FY2023)

Focus: Impact Therapeutics is a Shanghai-based biotech company focused on small-molecule oncology and multi-indication therapeutics in early-to-mid stage development. The company is at Series C+ funding stage with a concentrated pipeline primarily in solid tumors and hematologic malignancies.

Oncology Infectious Diseases Hematology Neurology

Profile data last refreshed 2d ago · AI intelligence enriched 2w ago

Funding Stage

SERIES C +

Open Jobs

About Impact Therapeutics

AI assessmentNot Hiring

No open roles listed right now. Follow Impact Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Receives mobile banking account with incentives to save

Human Immunodeficiency Virus

N/A

Provision of multiple self-tests

Human Immunodeficiency Virus

N/A

Clinical Trials (1)

Help build intelligence for Impact Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Access to Chinese market expansion and Asia-Pacific clinical development infrastructure with multiple Phase 1/2 oncology programs underway
Exposure to small-molecule drug discovery in high-value oncology indications (ovarian cancer, solid tumors, hematology) with IMP4927 advancing to Phase 3
Established H1B sponsorship track record (1 approval, 0 denials in 2023) demonstrates willingness to hire international talent

Watch Out For

Zero active job openings at time of analysis suggests company may not be actively hiring or is in organizational transition
Limited public information on funding, revenue, employee count, and R&D intensity makes career growth trajectory and compensation competitiveness difficult to assess
Data quality issues in pipeline listing (non-clinical interventions mixed with drug candidates) suggest possible data governance or reporting inconsistencies

Generated by Claude from Impact Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

NCT04805112Acceptability, Feasibility and Impact of Oral HIV Self-testing for Partner Testing Among Kenyan Adolescent Girls Aged 15-19 Years: A Randomized Controlled Trial

N/A

Prize-linked savings

HIV/AIDS

N/A

Clinical Trials (1)

NCT04013295Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya

N/A

Financial incentives for adherence to long-acting injectable medication

Schizophrenia Disorder

N/A

Provision of multiple self-tests

Human Immunodeficiency Virus

N/A

Clinical Trials (1)

NCT03135067Secondary Distribution of HIV Self-tests: an Innovative Strategy for Promoting Partner Testing and Reducing HIV Risk

N/A

Oral HIV Self-Testing

HIV Infection

N/A

Clinical Trials (1)

NCT02846402Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda

N/A

Oral HIV Self-Testing

HIV Infection

N/A

Clinical Trials (1)

NCT02827240Zambian Peer-Educators for HIV Self-Testing Study

N/A

The prismatic adaptation

Chronic Right Supratensorial Stroke Patients

N/A

Clinical Trials (1)

NCT03154138Prismatic Adaptation for Rehabilitation of Postural Imbalance After Stroke

N/A

Inter-personal Communication

HIV/AIDS

N/A

Clinical Trials (1)

NCT02497989Evaluating Demand Creation Strategies for Voluntary Medical Male Circumcision (VMMC) in Kenya

N/A

Oral Fedratinib

Myelofibrosis

N/A

Provision of multiple self-tests

Human Immunodeficiency Virus

N/A

Clinical Trials (1)

NCT04772469Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

N/A

Intervention

HIV Testing

N/A

Modified Health Policy Project

Mental Health Disorder

N/A

Clinical Trials (1)

NCT05415891The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta

N/A

Peer Support

HIV

N/A

Clinical Trials (1)

NCT03988387IPREP Study #2: Evaluating Enhanced PrEP Packages for Young Female Sex Workers in Kisumu, Kenya

N/A

Pen and paper neuropsychological test

Brain Concussion

N/A

Clinical Trials (1)

NCT02597504Development of a Neurocognitive Screening Test

N/A

Egg intervention

Weight Gain

N/A

Clinical Trials (1)

NCT04694235Egg Intervention During Pregnancy in Indonesia

N/A

NPOWER365 HIV care intervention

Sexual and Gender Minorities

N/A

Clinical Trials (1)

NCT06315218Examining the Health Effects of NPOWER365 Among Black Same Gender Loving Men

N/A

ImPACT Online/Paper Pencil Tests

Brain Concussion

N/A

Clinical Trials (1)

NCT03180905ImPACT Normative Extension

N/A

Normative

Concussion

N/A

Clinical Trials (1)

NCT05551520ImPACT Version 4-Touchscreen: Normative and Reliability Study

N/A

ImPACT Online/Paper Pencil Tests

Brain Concussion

N/A

Clinical Trials (1)

NCT02701842ImPACT Online Clinical Study

N/A

ART home delivery

HIV

N/A

Clinical Trials (1)

NCT02711293The Impact of Home Delivery of Antiretroviral Therapy on Virological Suppression

N/A

Near vision glasses for presbyopia correction

Presbyopia Correction

N/A

Clinical Trials (1)

NCT06774183Effect of Presbyopia Correction on Livelihood and Repayment Among Solar Customers in Western Region, Kenya

N/A

Tu'Washindi intervention

Gender-Based Violence

N/A

Clinical Trials (1)

NCT03938818Tu'Washindi na PrEP: Adolescent Girls in Kenya Taking Control of Their Health

N/A

Male-Specific Intervention Package

HIV

N/A

Clinical Trials (1)

NCT01571128Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)

N/A

Provision of household latrines

Diarrhoea

N/A

Clinical Trials (1)

NCT01214785Cluster Randomised Trial of Improved Sanitation in Rural Orissa, India

N/A

Responsible Engaged and Loving

Violence, Gender-Based

N/A

Clinical Trials (1)

NCT06100679Responsible Engaged and Loving (REAL) Fathers Intervention Evaluation

N/A

iTHRIVE 365

Medication Adherence

N/A

Clinical Trials (1)

NCT05376397Testing THRIVE 365 for Black Sexual Minority Men (On The Daily)

N/A

HIV self-testing

HIV

N/A

Clinical Trials (1)

NCT05882916Reaching the Last 20% (the Pamoja Kwa Afya Study)

N/A

Compensation for transport cost

Voluntary Medical Male Circumcision

N/A

Clinical Trials (1)

NCT01857700Economic Compensation to Increase Demand for Voluntary Medical Male Circumcision

N/A

SMART Randomization 1 - Referral

HIV

N/A

HIV self-test

HIV

N/A

Clinical Trials (1)

NCT02386215The Use of HIV Self-tests to Promote Partner and Couples Testing: a Randomized Trial

N/A

Experimental: Treatment 1

Obstetric Labor Complications

N/A

Clinical Trials (1)

NCT01480544Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE)

N/A

RCT 1- Testing the Effectiveness of Marketing Messages in Increasing Willingness to Pay

Air Pollution, Indoor

N/A

Trauma Resilience & Understanding Self-help Therapy

Domestic Violence

N/A

Community Health Worker intervention

Vertical Transmission of Infectious Disease

N/A

Clinical Trials (1)

NCT03058484Community Health Workers and Prevention of Mother-to-Child HIV Transmission in Tanzania

N/A

Tu'Washindi

IPV

N/A

Clinical Trials (1)

NCT05599581Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health

N/A

IMP4297

Advanced Solid Tumours

Phase 1

Clinical Trials (1)

NCT03508011A Study of IMP4297 in Patients With Advanced Solid Tumors

Phase 1

Fedratinib

Healthy Volunteers

Phase 1

IMP4297

Solid Tumor

Phase 1

Clinical Trials (1)

NCT04057729IMP4297 Food Effect Trial in Healthy Volunteers

Phase 1

Senaparib 10 mg strength capsules manufactured by WuXi STA

Solid Tumor

Phase 1

Clinical Trials (1)

NCT07030439A Bioequivalence Study to Compare Senaparib Manufactured at 2 Sites in Healthy Subjects in Fasting State

Phase 1

Padeliporfin Vascular Targeted Photodynamic

Locally Advanced Unresectable Pancreatic Adenocarcinoma

Phase 1

Clinical Trials (1)

NCT05919238Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma

Phase 1

Fedratinib

Healthy Volunteers

Phase 1

Fedratinib

Healthy Volunteers

Phase 1

LY2510924

Leukemia

Phase 1

Padeliporfin Vascular Targeted Photodynamic

Peripheral Lung Tumor

Phase 1

Clinical Trials (1)

NCT05918783Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer

Phase 1

UrSure Rapid Urine Tenofovir Test

HIV

Phase 1

Clinical Trials (1)

NCT04898699IPrEP Men's Study: Expanding the Reach of Prevention for Men in Kisumu, Kenya

Phase 1

IMP4297

Solid Tumor

Phase 1

Clinical Trials (1)

NCT05391048An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition

Phase 1

IMP4297 40 mg

Solid Tumor

Phase 1

Clinical Trials (1)

NCT04584515IMP4297 DDI (Drug-Drug Interaction)Trial in Healthy Male Volunteers

Phase 1

IMP4297

Solid Tumor

Phase 1

Clinical Trials (1)

NCT04351165BA Study of IMP4297 (20mg vs 10mg) in Healthy Male Subjects

Phase 1

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 53 clinical trials

Top TAs: Oncology, Infectious Diseases, Neurology

H-1B (2023): 1 approval

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

19 pipeline

17 pipeline

3 pipeline

2 pipeline

Marketed

Pipeline

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub